TrialMicrobiology spectrum2024

Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT).

Matthew G Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.